These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1846711)

  • 1. Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer.
    Culver KW; Osborne WR; Miller AD; Fleisher TA; Berger M; Anderson WF; Blaese RM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):170-1. PubMed ID: 1846711
    [No Abstract]   [Full Text] [Related]  

  • 2. Retroviral-mediated gene transfer into mammalian cells.
    Kohn DB; Kantoff PW; Eglitis MA; McLachlin JR; Moen RC; Karson E; Zwiebel JA; Nienhuis A; Karlsson S; O'Reilly R
    Blood Cells; 1987; 13(1-2):285-98. PubMed ID: 3311223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroviral-mediated gene transfer into hematopoietic cells.
    Kantoff PW; Gillio A; McLachlin JR; Flake AW; Eglitis MA; Moen R; Karlsson S; Kohn DB; Karson E; Zwiebel JA
    Trans Assoc Am Physicians; 1986; 99():92-102. PubMed ID: 3299988
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of T cell-directed gene transfer for a patient with ADA deficiency].
    Sakiyama Y; Ariga T; Kawamura N
    Nihon Rinsho; 1998 Mar; 56(3):696-700. PubMed ID: 9549359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow gene therapy for adenosine deaminase deficiency.
    Kaptein LC; Einerhand MP; Braakman E; Valerio D; van Beusechem VW
    Immunodeficiency; 1993; 4(1-4):335-45. PubMed ID: 7909479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of the induced T cells in a ADA-defective case 4 years after gene induction targeted at the peripheral T cells and a simulation study on gene re-induction].
    Ichimura R
    Hokkaido Igaku Zasshi; 2004 Nov; 79(6):647-57. PubMed ID: 15675295
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gene therapy for adenosine deaminase deficiency].
    Sakiyama Y
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):27-32. PubMed ID: 8727372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer and expression of human ADA in murine hematopoietic stem cells.
    Williams DA; Lim B; Orkin SH
    Prog Clin Biol Res; 1987; 251():567-80. PubMed ID: 3432278
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel strategies for the selection of cells expressing human adenosine deaminase and their application in experimental gene therapy protocols.
    Shen Q; Van Beusechem VW; Hendrikx PJ; Valerio D
    Allergol Immunopathol (Madr); 1991; 19(1):29-31. PubMed ID: 1659164
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic correction of cultured T cells from an adenosine deaminase-deficient patient: characteristics of non-transduced and transduced T cells.
    Braakman E; Van Beusechem VW; Van Krimpen BA; Fischer A; Bolhuis RL; Valerio D
    Eur J Immunol; 1992 Jan; 22(1):63-9. PubMed ID: 1730260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial.
    Muul LM; Tuschong LM; Soenen SL; Jagadeesh GJ; Ramsey WJ; Long Z; Carter CS; Garabedian EK; Alleyne M; Brown M; Bernstein W; Schurman SH; Fleisher TA; Leitman SF; Dunbar CE; Blaese RM; Candotti F
    Blood; 2003 Apr; 101(7):2563-9. PubMed ID: 12456496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of proliferative responses in purine nucleoside phosphorylase (PNP)-deficient T lymphocytes by retroviral-mediated PNP gene transfer and expression.
    Nelson DM; Butters KA; Markert ML; Reinsmoen NL; McIvor RS
    J Immunol; 1995 Mar; 154(6):3006-14. PubMed ID: 7876563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice.
    Westwood JA; Murray WK; Trivett M; Shin A; Neeson P; MacGregor DP; Haynes NM; Trapani JA; Mayura-Guru P; Fox S; Peinert S; Honemann D; Prince HM; Ritchie D; Scott AM; Smyth FE; Smyth MJ; Darcy PK; Kershaw MH
    Gene Ther; 2008 Jul; 15(14):1056-66. PubMed ID: 18369322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
    Hershfield MS
    Semin Hematol; 1998 Oct; 35(4):291-8. PubMed ID: 9801258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfer therapy for heritable disease: cell and expression targeting.
    Mitani K; Clemens PR; Moseley AB; Caskey CT
    Philos Trans R Soc Lond B Biol Sci; 1993 Feb; 339(1288):217-24. PubMed ID: 8097051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
    Blesch A
    Methods; 2004 Jun; 33(2):164-72. PubMed ID: 15121171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer.
    Kantoff PW; Kohn DB; Mitsuya H; Armentano D; Sieberg M; Zwiebel JA; Eglitis MA; McLachlin JR; Wiginton DA; Hutton JJ
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6563-7. PubMed ID: 3489233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte gene therapy.
    Culver KW; Anderson WF; Blaese RM
    Hum Gene Ther; 1991; 2(2):107-9. PubMed ID: 1911929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functions.
    Ferrari G; Rossini S; Nobili N; Maggioni D; Garofalo A; Giavazzi R; Mavilio F; Bordignon C
    Blood; 1992 Sep; 80(5):1120-4. PubMed ID: 1325209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directions in gene therapy.
    Moen RC
    Blood Cells; 1991; 17(2):407-16. PubMed ID: 1912600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.